Xenotransplantation is the use of cells, tissues or organs from another species as a solution for the shortage of organs for transplant. Discover the latest research on Xenotransplantation here.

February 1, 2020

Xenoantibodies and Complement Activity Determinations by Flow Cytometry in Pig-to-Primate Xenotransplantation

Methods in Molecular Biology
Nieves Doménech, Pilar Sánchez-Corral
September 15, 2020
Open Access

Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells

Roberta SommaggioAntonio Rosato
August 25, 2020

What Are the Immune Obstacles to Liver Xenotransplantation Which Is Promising for Patients with Hepatocellular Carcinoma?

Journal of Gastrointestinal Cancer
Sezai YilmazKutay Saglam
April 11, 2020

Porcine genome engineering for xenotransplantation

Advanced Drug Delivery Reviews
Dong NiuGeorge M Church
June 20, 2020
Open Access

FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion

Journal for Immunotherapy of Cancer
Robert J OldhamMark S Cragg
September 13, 2020

Anti-tumor effect of single-chain antibody to Reg3a in colorectal cancer

Experimental Cell Research
Pei DuLuting Yu
July 3, 2020
Open Access

Heterotopic Porcine Cardiac Xenotransplantation in the Intra-Abdominal Position in a Non-Human Primate Model

Scientific Reports
Corbin E GoerlichMuhammad M Mohiuddin
August 17, 2020
Open Access

Anti-Pig IGE and IGA Antibodies in Naive Primates and Nonhuman Primates With Pig Xenografts

Qi LiHidetaka Hara
February 1, 2020

3D Cell-Culture Models for the Assessment of Anticoagulant and Anti-Inflammatory Properties of Endothelial Cells

Methods in Molecular Biology
Riccardo Sfriso, Robert Rieben
November 26, 2019

Profiling natural serum antibodies of non-human primates with a carbohydrate antigen microarray

Yoshihide NannoChristopher Burlak
September 18, 2020

B cell acute lymphoblastic leukemia cells mediate RANK-RANKL-dependent bone destruction

Science Translational Medicine
Sujeetha A RajakumarJayne S Danska
December 6, 2019
Open Access

Comparative Analysis of Roseoloviruses in Humans, Pigs, Mice, and Other Species

Joachim DennerBenedikt B Kaufer
August 19, 2020
Open Access

Cytokine-inducible promoters to drive dynamic transgene expression: The "Smart Graft" strategy

Andrea FischerKonrad Fischer

Sign up to follow this feed and discover related papers.

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.


Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.


Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

© 2020 Meta ULC. All rights reserved